CIK 0001559053
- Accelerated filer
PROTHENA CORP PUBLIC LTD CO
Sign in to watch- Ticker
- PRTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- Operating
- Phone
- +353 12362500
- Business address
- 77 SIR JOHN ROGERSON'S QUAY, BLOCK C, GRAND CANAL DOCKLANDS, DUBLIN 2, Ireland, D02 VK60
- Former names
- Prothena Corp plc, Neotope Corp Ltd
- Open-market buys, last 90 days
- $9,848,721
- in 10 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,848,721. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-05-22 | Harfstrand Karl Anders Olof Director | Grant or award · Stock Option (Right to Buy) | +17,500 | 17,500 | ||
| 2019-05-22 | HENNEY CHRISTOPHER S Director | Grant or award · Stock Option (Right to Buy) | +17,500 | 17,500 | ||
| 2019-05-22 | Selkoe Dennis J. Director | Grant or award · Stock Option (Right to Buy) | +17,500 | 17,500 | ||
| 2019-05-22 | Ekman Lars Director | Grant or award · Stock Option (Right to Buy) | +17,500 | 17,500 | ||
| 2019-02-27 | Kinney Gene G. President and CEO | Grant or award · Stock Option (right to buy) | +245,000 | 245,000 | ||
| 2019-02-27 | Nguyen Tran See Remarks | Grant or award · Stock Option (right to buy) | +95,000 | 95,000 | ||
| 2019-02-27 | Karp Carol D. Chief Regulatory Officer | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2019-02-27 | Zago Wagner M. Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2019-02-27 | Walker Karin L See Remarks | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2019-02-27 | Tripuraneni Radhika Chief Development Officer | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2018-12-11 | Tripuraneni Radhika Chief Development Officer | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2018-06-21 | HOMAN ARTHUR W Chief Legal Officer | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2018-06-21 | Nguyen Tran COO and CFO | Grant or award · Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2018-06-21 | Karp Carol D. Chief Regulatory Officer | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2018-06-21 | Zago Wagner M. Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2018-06-21 | Walker Karin L See Remarks | Grant or award · Stock Option (right to buy) | +110,000 | 110,000 | ||
| 2018-06-21 | Kinney Gene G. President and CEO | Grant or award · Stock Option (right to buy) | +620,000 | 620,000 | ||
| 2018-05-16 | Selkoe Dennis J. Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2018-05-16 | Ekman Lars Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 |
Page 41 of 41 · 819 trades